Novel thermosensitive small multilamellar lipid nanoparticles with promising release characteristics made by dual centrifugationShow others and affiliations
2025 (English)In: European Journal of Pharmaceutical Sciences, ISSN 0928-0987, E-ISSN 1879-0720, Vol. 206, article id 106999Article in journal (Refereed) Published
Abstract [en]
Thermosensitive liposomes (TSLs) have great potential for the selective delivery of cytostatic drugs to the tumor site with greatly reduced side effects. Here we report the discovery and characterization of new thermosensitive small multilamellar lipid nanoparticles (tSMLPs) with unusually high temperature selectivity. Furthermore, the temperature-dependent release of the fluorescent marker calcein from tSMLPs is enhanced by human serum albumin. tSMLPs can easily be prepared through dual centrifugation (DC) at very high lipid concentrations using dipalmitoyl and distearoyl phosphatidylcholine (DPPC, DSPC) and the phospholipid dipalmitoyl-sn-glycero-phosphatidyldiglycerol (DPPG2). The new particles have a hydrodynamic diameter of about 175 nm and a narrow size distribution (PDI 0.02). tSMLPs consist of multiple lipid membranes, which become increasingly closer packed towards the particle center, and have no visible aqueous core. The particles are highly stable due to strong hydrogen bond-based membrane interactions mediated by DPPG2. tSMLPs can be used as carriers for water-soluble drugs (EE 25 %) entrapped within the interlamellar spaces. Based on biophysical (DSC, DLS and ITC) and morphological (cryo-EM) studies, a hypothesis is presented to explain the structural basis underlying the high temperature selectivity, as well as the unusual morphology of the new thermosensitive lipid nanoparticles.
Place, publisher, year, edition, pages
Elsevier, 2025. Vol. 206, article id 106999
Keywords [en]
Dual centrifugation, In-vial homogenization, Thermosensitive liposomes, Liposomes, DPPG 2, Small multilamellar vesicles, Multilamellar liposomes, Drug delivery
National Category
Physical Chemistry Biophysics
Identifiers
URN: urn:nbn:se:uu:diva-549595DOI: 10.1016/j.ejps.2024.106999ISI: 001400412800001PubMedID: 39730031Scopus ID: 2-s2.0-85213868157OAI: oai:DiVA.org:uu-549595DiVA, id: diva2:1935213
Funder
Swedish Cancer Society, 20 0987Swedish Cancer Society, 23 27982025-02-062025-02-062025-02-06Bibliographically approved